Aurinia Pharmaceuticals Inc (AUPH)

Currency in USD
9.070
-0.120(-1.31%)
Closed·
After Hours
9.031-0.039(-0.43%)
·

AUPH Earnings

Latest Release
May 12, 2025
EPS / Forecast
0.16 / 0.11
Revenue / Forecast
62.50M / 62.55M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/0.144--/64.27M----Free Sign Up
03/20250.16/0.1162.5M/62.55M+45.45%-0.08%Free Sign Up
12/20240.01/0.0359.9M/61.7M-66.67%-2.92%Free Sign Up
09/20240.1/0.0267.77M/57.48M+400%+17.9%Free Sign Up
06/20240.01/0.0157.2M/54.25M0%+5.44%Free Sign Up
03/2024-0.07/-0.1448.1M/47.07M+50%+2.19%Free Sign Up
12/2023-0.19/-0.1645.1M/44.2M-18.75%+2.04%Free Sign Up
09/2023-0.09/-0.1740.8M/38.44M+47.06%+6.14%Free Sign Up
06/2023-0.08/-0.1841.49M/37.9M+55.56%+9.47%Free Sign Up
03/2023-0.18/-0.2534.4M/28.12M+28%+22.33%Free Sign Up

All numbers in USD

Aurinia Pharmaceuticals Inc Earnings Call Summary for Q4/2024

  • Q4 2024 EPS of $0.01 missed $0.03 forecast; revenue of $59.9M fell short of $61.7M projection, leading to 4.65% stock drop
  • 2024 total revenue up 34% YoY to $235.1M; LUKINIS net sales reached $216.2M, a 36% increase from 2023
  • 2025 guidance: total revenue $250-260M, net product sales $240-250M; company advancing pipeline, particularly AUR200
  • Strong liquidity with $358.5M cash/investments; cash flow from operations $44.4M for 2024; current ratio 5.6
  • CEO emphasized historical results provide insight for projections; company preparing for potential generic competition
Last Updated: 27/02/2025, 15:34
Read Full Transcript

FAQ

What Is Aurinia Pharma's Earnings Per Share (TTM)?

The Aurinia Pharma EPS (TTM) is 0.28.

When Is The Next Aurinia Pharma Earnings Date?

Aurinia Pharma will release its next earnings report on 30 Jul 2025.

What Is Aurinia Pharma’s Revenue Forecasts For Upcoming Quarters?

Aurinia Pharma’s revenue forecast is 64.27M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.